Posterior reversible leukoencephalopathy syndrome: Case series and review of the literature.
Síndrome de leucoencefalopatía posterior reversible: serie de casos y revisión de la literatura.
Hipertensión
Hypertension
Magnetic resonance imaging
Posterior reversible encephalopathy syndrome
Resonancia magnética nuclear
Síndrome de leucoencefalopatía posterior reversible
Journal
Reumatologia clinica
ISSN: 2173-5743
Titre abrégé: Reumatol Clin (Engl Ed)
Pays: Spain
ID NLM: 101717526
Informations de publication
Date de publication:
Historique:
received:
20
12
2017
revised:
19
04
2018
accepted:
19
04
2018
pubmed:
4
6
2018
medline:
6
8
2021
entrez:
4
6
2018
Statut:
ppublish
Résumé
To describe clinical manifestations, antecedents, comorbidities and associated treatments, imaging findings, and follow-up in patients with posterior reversible encephalopathy syndrome. A retrospective, descriptive analysis of admitted patients was performed between June 2009 and May 2014 in a third-level care hospital. We evaluated age, sex, comorbidities, symptoms, values of blood pressure at admission, renal function, medication and time elapsed until the disappearance of symptoms. Thirteen patients were included. In all, 77% of them had a history of hypertension at baseline and 85% had impaired renal function. The most prevalent comorbidity was renal transplantation, and 85% had deterioration of renal function. Five of the patients had undergone renal transplantation. The most common clinical manifestation was seizures. All had subcortical lesions and bilateral parietooccipital involvement was the finding most frequently observed. This syndrome should be taken into account in the differential diagnoses of patients presenting with acute neurological syndromes and the abovementioned risk factors.
Identifiants
pubmed: 29859809
pii: S1699-258X(18)30112-8
doi: 10.1016/j.reuma.2018.04.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
169-173Informations de copyright
Copyright © 2018 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.